Geode Capital Management, LLC Cue Biopharma, Inc. Call Options Transaction History
Geode Capital Management, LLC
- $1.39 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CUE
# of Institutions
48Shares Held
17.7MCall Options Held
0Put Options Held
0-
Bleichroeder LP New York, NY6.82MShares$5.39 Million1.47% of portfolio
-
Catalytic Wealth Ria, LLC Cambridge, MA3.33MShares$2.63 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.19MShares$2.52 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$597,8210.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$378,0150.01% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $28M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...